| Id |
Subject |
Object |
Predicate |
Lexical cue |
| SS1_21211797_2_0 |
281-635 |
expanded |
denotes |
MBL2 gene and its promoter, and especially haplotypes, determine MBL plasma levels. MBL deficiency has been associated with the development of atherosclerosis. We evaluated whether the rate of angiographic progression of coronary atherosclerosis during pravastatin treatment was associated with MBL2 haplotypes in REGRESS, a placebo-controlled 2 years in |
| SS2_21211797_2_0 |
740-743 |
abbr |
denotes |
MBL |
| SS1_21211797_11_0 |
1063-1084 |
expanded |
denotes |
mean segment diameter |
| SS2_21211797_11_0 |
1086-1089 |
abbr |
denotes |
MSD |
| SS1_21211797_11_1 |
1095-1123 |
expanded |
denotes |
minimum obstruction diameter |
| SS2_21211797_11_1 |
1125-1128 |
abbr |
denotes |
MOD |
| AE1_21211797_11_0 |
SS1_21211797_11_0 |
SS2_21211797_11_0 |
abbreviatedTo |
mean segment diameter,MSD |
| AE1_21211797_11_1 |
SS1_21211797_11_1 |
SS2_21211797_11_1 |
abbreviatedTo |
minimum obstruction diameter,MOD |
| AE1_21211797_2_0 |
SS1_21211797_2_0 |
SS2_21211797_2_0 |
abbreviatedTo |
"MBL2 gene and its promoter, and especially haplotypes, determine MBL plasma levels. MBL deficiency has been associated with the development of atherosclerosis. We evaluated whether the rate of angiographic progression of coronary atherosclerosis during pravastatin treatment was associated with MBL2 haplotypes in REGRESS, a placebo-controlled 2 years in",MBL |
